TipRanks
Go Ultimate55% OFF

ANI Pharmaceuticals (BSFA) Hedge Fund Trading Activity

Trend: ▲ Hedge Funds Increased Holdings by 769.3K Shares Last Quarter

Hedge Fund Holdings in BSFA

0.00EUR 50.0080.00KEUR 58.50160.00KEUR 67.00240.00KEUR 75.50320.00KEUR 84.00Jul '24Jan '25Jul '25Jan '26Jul '26EUR 64.00Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
Hedge Fund ManagerStar RankingFirmActivityHolding ChangeValue Reported% of PortfolioFollow
John Hussman hedge funds manager, Hussman Strategic Advisors Inc,Rank 286John HussmanHussman Strategic Advisors IncNew100.00%$2,486,6100.60%
Kenneth Tropin hedge funds manager, Graham Capital Management, L.P.,Rank 368Kenneth TropinGraham Capital Management, L.P.Added57.02%$466,2980.01%
George Davis Jr hedge funds manager, Hotchkis & Wiley Capital Management LLC,Rank 436George Davis JrHotchkis & Wiley Capital Management LLCAdded0.43%$5,903,1330.02%
Bernard Horm hedge funds manager, Polaris Capital Management LLC,Rank 171Bernard HormPolaris Capital Management LLCNot Changed0.00%$765,7180.06%
Richard Driehaus hedge funds manager, Driehaus Capital Management LLC,Rank 450Richard DriehausDriehaus Capital Management LLCReduced-3.34%$6,013,6490.04%

FAQ

Which hedge funds hold ANI Pharmaceuticals?
The hedge funds that hold the most shares in ANI Pharmaceuticals are Richard Driehaus, George Davis Jr and John Hussman.
Are hedge funds buying or selling DE:BSFA?
In the last quarter hedge funds have Increased their holdings in ANI Pharmaceuticals by 769.3K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in ANI Pharmaceuticals stock?
Warren Buffet currently does not own shares in ANI Pharmaceuticals.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here